Luis Eduardo Jáuregui Ilabaca

797 posts

Luis Eduardo Jáuregui Ilabaca banner
Luis Eduardo Jáuregui Ilabaca

Luis Eduardo Jáuregui Ilabaca

@Edu_Jauregui

Urologist @UroINNSZ - Interested in urologic oncology and endourology Fellowship in Endourology and Robotic Surgery @UANL Monterrey

Monterrey, Nuevo Leon Katılım Nisan 2018
508 Takip Edilen269 Takipçiler
Sabitlenmiş Tweet
Luis Eduardo Jáuregui Ilabaca
Luis Eduardo Jáuregui Ilabaca@Edu_Jauregui·
This weekend it's so special 'cause i've finally achieved one of my greatest dreams Certified Urologist by the @CONAMEU1 and my second home INCMNSZ Thanks to each and everyone that stood by my side along this amazing journey. My family, friends and professors! This is for you
Luis Eduardo Jáuregui Ilabaca tweet media
Distrito Federal, México 🇲🇽 English
7
1
39
0
Luis Eduardo Jáuregui Ilabaca retweetledi
Jeff Tosoian, MD, MPH
We can say it again - prostate MRI is highly informative when positive, but it is not very informative and often misleading when negative. MRI is simply NOT a reliable rule out test in most settings. Apply clinically with caution. Great talk by Wayne Brisbane. #AUA26
Jeff Tosoian, MD, MPH tweet mediaJeff Tosoian, MD, MPH tweet media
English
2
7
36
3.1K
Luis Eduardo Jáuregui Ilabaca retweetledi
Alexander Kutikov MD
Alexander Kutikov MD@uretericbud·
Very impressive John K. Lattimer Lecture: Transurethral Robotic en-bloc TURBT- Challenging the Status Quo by @jteoh_hk #bladdercancer surgeons must take note. #aua26
Alexander Kutikov MD tweet mediaAlexander Kutikov MD tweet mediaAlexander Kutikov MD tweet media
English
5
34
170
12.2K
Luis Eduardo Jáuregui Ilabaca retweetledi
Abhishek singh
Abhishek singh@abhisingh82·
Post robotic radical cystectomy , creating stoma was extremely tedious in this patient. Patient was extremely obese BMI -42. Did a turnbull stoma and put a red rubber catheter through the mesentery to prevent retraction. As you would do for loop colostomy. Open to suggestions!!
Abhishek singh tweet mediaAbhishek singh tweet mediaAbhishek singh tweet media
English
9
6
115
20.9K
Luis Eduardo Jáuregui Ilabaca retweetledi
Dmitry Enikeev
Dmitry Enikeev@Dmitry_Enikeev·
Breaking this paradigm. Large bladder tumors can be safely removed with laser en bloc, followed by morcellation. High quality pathology. Better outcomes. Pathologists are happy and so are we. @DrShariat @shaygo1 @trwherrmann @jteoh_hk @scoffonecesare
English
4
2
31
1.4K
Luis Eduardo Jáuregui Ilabaca retweetledi
Dra. María Natalia Gandur Quiroga
💫🌟 Redefining GU cancer precursors @EUplatinum @OncoAlert 🌍 ISUP Consensus (Florence) sets a NEW framework for GU premalignant lesions: 🔵 Prostate: IDC → must report (aggressive biology) 🟡 Bladder: CIS remains key precursor 🟠 Kidney: Papillary adenoma = only established precursor 🟢 Testis: GCNIS → definitive precursor 🔴 Penis: PeIN unified classification 📌 Standardization = better diagnosis & clinical decision-making 🔗 europeanurology.com/article/S0302-… 🔗 authors.elsevier.com/a/1mtG514kpm4a… @ecancer @urotoday @MedicalwatchHQ @ASCOPres @DrYukselUrun @montypal @PGrivasMDPhD @tompowles1 @shilpaonc @neerajaiims @UroDocAsh @TiansterZhang @gbanna74 @katy_beckermann @DrKarineTawagi #GUOncology #UroPath #PrecisionMedicine #ProstateCancer #BladderCancer #OncoTwitter
Dra. María Natalia Gandur Quiroga tweet media
English
1
14
38
3.1K
Luis Eduardo Jáuregui Ilabaca retweetledi
Álex Maceín
Álex Maceín@AlexMacein·
“Solo ha subido un poco la creatinina” 💦La Cr no solo estima función renal.También orienta a Insuficiencia Renal Aguda o si se trata de más Enfermedad Renal Crónica… 📉 IRA → pequeños ↑ pueden implicar gran ↓ del FG 📉 ERC → grandes ↑ suelen asociar menor cambio relativo
Álex Maceín tweet media
Español
1
69
271
9.7K
Luis Eduardo Jáuregui Ilabaca retweetledi
NEJM
NEJM@NEJM·
In cisplatin-ineligible patients with muscle-invasive bladder cancer, enfortumab vedotin–pembrolizumab plus surgery led to better event-free survival (74.7%, vs. 39.4%) and overall survival (79.7%, vs. 63.1%) than surgery alone at 2 years. Full phase 3 KEYNOTE-905 trial results and Research Summary: nejm.org/doi/full/10.10…
NEJM tweet media
English
0
61
156
14.5K
Luis Eduardo Jáuregui Ilabaca retweetledi
Mario Sofer
Mario Sofer@mario_sofer·
How to report prostate volume in HoLEP literature? Preoperative US, TRUS, MRI? Resected tissue weighted in the OR? Pathological report? Is the time for standardization!! ⁦@UrologyTLVMC⁩ ⁦@scoffonecesare⁩ ⁦@fgomsan⁩ ⁦@FCAFigueiredo
Mario Sofer tweet media
English
6
17
66
4.6K
Luis Eduardo Jáuregui Ilabaca retweetledi
Ryan L. Steinberg MD
Ryan L. Steinberg MD@ryansteinbergmd·
Must read for all uros since we ALL order CTs w contrast for various reasons. We are part of the fight to change this misconception to ensure our patients get the imaging (and thus care) they need! @ChadTracyMD @Allyhertz @TheBigLoeb @AmandaMyersMD @baerickson29 @AnnahVollstedt
Dr. Chacón-Lozsán F .'.@franciscojlk

🩻Contrast-induced AKI: one of the biggest myths still shaping clinical decisions For decades we were taught: 👉 “Contrast damages the kidneys” 👉 “Avoid CT with contrast in CKD” 👉 “Hydrate, protect, delay imaging if needed” But what if… most of this is wrong?🤔 ->The uncomfortable reality Modern evidence shows: 👉 Low-osmolar contrast rarely causes true nephrotoxicity 👉 Even in CKD, AKI, and ICU patients 👉 The risk is often overestimated—or nonexistent So where did the fear come from? 📍 1950s high-osmolar contrast (actually toxic) 📍 Poorly controlled observational studies 📍 “Creatinine rise = contrast injury” assumption 👉 Correlation became causation 👉 And the dogma stayed ⚠️What recent data tells us ✔ No difference in AKI rates with vs without contrast ✔ No benefit from bicarbonate, NAC, or aggressive hydration ✔ Even ICU and AKI patients show no worsening outcomes ->Translation to real life 👉 The patient was going to develop AKI anyway...Not because of contrast!! ->The real problem: “Renalism” 👉 Avoiding necessary imaging 👉 Delaying diagnosis 👉 Choosing inferior tests And that leads to: ❌ Missed PE ❌ Delayed sepsis source control ❌ Worse outcomes ->Clinical mindset shift Instead of asking: 👉 “Will contrast harm the kidneys?” We should ask: 👉 “Will NOT doing the scan harm the patient?” ->Who still deserves caution? ✔ eGFR <30 ✔ Severe hemodynamic instability ✔ Multiple nephrotoxins Even then: 👉 Optimize volume 👉 Minimize dose 👉 Don’t delay critical imaging 🤓Bottom line ✔ Contrast nephrotoxicity exists… but is rare ✔ The fear is bigger than the risk ✔ The harm of NOT imaging is often greater In critical care 👉 We don’t treat creatinine 👉 We treat patients And sometimes… 👉 The most dangerous thing is NOT the contrast 👉 It’s hesitation. 📃Reference Florens N, Demiselle J. Kidney360 7: 445–449, 2026. doi: doi.org/10.34067/KID.0…

English
0
6
38
8.6K
Luis Eduardo Jáuregui Ilabaca retweetledi
Fernando GomezSancha
Fernando GomezSancha@fgomsan·
Piedras en vejiga + próstata grande: ¿cirugía combinada o por pasos? Nuevo estudio multicéntrico analiza decisiones clínicas y resultados.  pubmed.ncbi.nlm.nih.gov/41789770/
Fernando GomezSancha tweet media
Español
1
12
52
4.4K
Luis Eduardo Jáuregui Ilabaca retweetledi
Michael Hofman
Michael Hofman@DrMHofman·
Proud moment and HUGE news from #EAU26: #PRIMARY2 shows PSMA PET/CT can safely halve prostate biopsies in men with equivocal MRI, avoiding biopsy in 49% without missing cancer. uroweb.org/news/scan-that…
English
9
75
254
20.8K
Luis Eduardo Jáuregui Ilabaca retweetledi
@DocMeetings - Urology
@DocMeetings - Urology@docmeetings·
PRostate cancer guidelines 2026 update. Digital rectal exam NOW no more recommended for Asymptomatic men SO NO MORE FOR Screening Important for standing and for early diagnosis for SYMPTOMS only @Uroweb
@DocMeetings - Urology tweet media@DocMeetings - Urology tweet media
English
4
91
219
34.6K
Luis Eduardo Jáuregui Ilabaca retweetledi
Dr. Carlos Ríos Melgarejo
Dr. Carlos Ríos Melgarejo@urologorios·
PRIMARY2 trial En hombres con sospecha de cáncer de próstata y mpMRI negativa o equívoca:•Sensibilidad: mpMRI sola → ~83% mpMRI + PSMA PET → ~94% El PSMA PET detecta tumores clínicamente significativos no visibles en MRI y mejora la selección para biopsia. #EAU2026 #PSMAPET
Dr. Carlos Ríos Melgarejo tweet media
Español
0
2
6
294
Luis Eduardo Jáuregui Ilabaca retweetledi
Ahmed M. Harraz
Ahmed M. Harraz@Ahmed_M_Harraz·
The supine lateral extraperitoneal approach for RPLND is an alternative when transperitoneal surgery is non-friendly. Length of stay < 48 hours. May Allah keep Kuwait, Egypt and all arabic countries safe and secure 🙏 #RPLND
English
9
12
119
14K
Luis Eduardo Jáuregui Ilabaca retweetledi
Fernando GomezSancha
Fernando GomezSancha@fgomsan·
Robotic reimplantation with a bypass technique for ureteroileal stricture post-cystectomy shows promising outcomes. The stepwise approach is commendable, but long-term follow-up is essential to validate these results. pubmed.ncbi.nlm.nih.gov/41697474/ #HoLEP #Urology
Fernando GomezSancha tweet media
English
1
4
41
3.9K
Luis Eduardo Jáuregui Ilabaca retweetledi
Fernando GomezSancha
Fernando GomezSancha@fgomsan·
¡Nueva técnica ThuFLEP para preservar la mucosa uretral en el ápex! Inspirada en mi concepto. Análisis de curva de aprendizaje en Frontiers in Surgery 2025. ✅ Técnica única y segura ✅ Datos perioperatorios óptimos ✅ Curva aprendizaje demostrada Lee más: pubmed.ncbi.nlm.nih.gov/41036283/ Próximo curso: AAU Jerez en Mayo: aauenucleacionprostata.com
Español
0
2
10
991
Luis Eduardo Jáuregui Ilabaca retweetledi
Mark (Toto) Abalajon MD
Mark (Toto) Abalajon MD@abalajontoto·
Presented with a case of prostate Ca, Gleason 9 (4 + 5), bilateral distal ureteral strictures. Me and my fellows performed radical prostatectomy with BPLND, with the Philippines’ first combined non-transecting ureteral reimplantation L, Uretero-Appendico-Vesical bypass R.
Mark (Toto) Abalajon MD tweet mediaMark (Toto) Abalajon MD tweet mediaMark (Toto) Abalajon MD tweet media
English
5
16
140
9.8K
Luis Eduardo Jáuregui Ilabaca retweetledi
MV Chandrakanth
MV Chandrakanth@ChandrakanthMv·
Cytoreductive nephrectomy in metastatic RCC has evolved. Not routine anymore. Start immunotherapy first. Restage. Operate only on responders. It’s no longer dogma — it’s biology-driven strategy. #RCC #KidneyCancer #Immunotherapy #MVOnco
MV Chandrakanth tweet media
English
1
48
139
7.6K